Biotechnology Stocks I Performance Guide: Keros Therapeutics, Inc. (KROS)
KROS has no dividends.
Table and Chart of KROS Performance
See what a $1,000 investment in KROS is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| KROS Returns | |
|---|---|
| Start Date | May-29-2020 |
| Start Price | $28.74 |
| End Date | Oct-03-2024 |
| End Price | $59.90 |
| # Prices | 54 |
| Min Date | Jun-30-2022 |
| Min Price | $27.63 |
| Max Date | Nov-30-2020 |
| Max Price | $75.61 |
| Total Return | 108.42% |
| Annualized Return | 17.73% |
| Current Value of $1,000 Purchase | $2,084 |
| Number Returns | 1,431 |
| Average Return | 6.85% |
| Number Profitable Returns | 703 |
| Percent Profitable Returns | 49.13% |
| Number Unprofitable Returns | 728 |
| Percent Unprofitable Returns | 50.87% |
| Profitable to Unprofitable Returns Ratio | 0.97 |
| KROS Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | -13.050 | Price to Sales |
| Earnings per Share | $0.0000 |
| PE Ratio | -187616992 |
| PE to Growth Ratio | None |
| Price to Book | 8488.86 |
| PRICE DATA | |
| 52 Week High | $1.222 |
| 52 Week Low | $73 |
| Analyst Target Price | $0 |
| 50-Day Moving Average | $27.02 |
| 200-Day Moving Average | $50.83 |
| FINANCIAL DATA | |
| Revenue per Share | $-5.13 |
| Revenue | $0 |
| Profit Margin | 0.8% |
| Return on Equity | -29.1% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
KROS Compare Returns with S&P 500
KROS Trendline Chart
KROS Moving Average Chart
KROS Stock Return Map - See Patterns of Gains and Losses
KROS Stock Returns/Purchase Dates